As many medical schools don’t have conflict of interest policies that are as strong as hospitals’, drug companies often market directly to young doctors and students to gain an advantage. Many drug companies spend billions in marketing to doctors and students which is more than they spend on research or marketing. The Association of American Medical Colleges hopes that by limiting drug companies’ access to students to help cure conflicts of interest, bias, and curb the reciprocal benefit exchange between doctors and drug companies. Hopefully, medical schools following this program might help to curb medical malpractice and conflicts of interest in the future.
Read the full article here.